SLC5A2 and diabetes mellitus: Of the 12 patients included in this review, all had diabetes, and 11 of them exhibited poor glycemic control at the onset of FG (glycosylated hemoglobin, HbAlc >7.0%), so there was still a risk of FG despite good glycemic management with SGLT-2 inhibitors.